Immune Therapies for Type 1 Diabetes

Immune therapies for Type 1 Diabetes (T1D) aim to prevent the autoimmune attack that destroys insulin-producing beta cells in the pancreas. In T1D, the body's immune system mistakenly targets and eliminates these cells, leading to lifelong insulin dependence. Researchers are investigating various immune-modulating strategies, such as immunosuppressive drugs, monoclonal antibodies, and vaccines, to halt or reverse this autoimmune response. Some therapies aim to "re-educate" the immune system, promoting tolerance to beta cells. Clinical trials are exploring the potential of these therapies to preserve or restore insulin production, offering hope for a cure or better management of T1D. While still in development, immune therapies could change the course of Type 1 Diabetes by addressing its root cause.

    Related Conference of Immune Therapies for Type 1 Diabetes

    February 09-10, 2026

    20th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    February 12-13, 2026

    5th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    February 25-26, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    March 09-10, 2026

    19th European Diabetes and Endocrinology Congress

    London, UK
    March 23-24, 2026

    25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Rome, Italy
    March 23-24, 2026

    21st International Conference on Endocrinology and Metabolic Disorders

    London, UK
    March 26-27, 2026

    5th World Congress on Diabetes and Pediatric Endocrinology

    London, UK
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    April 16-17, 2026

    10th International Conference on Diabetes and Cholesterol Metabolism

    Tokyo, Japan
    April 27-28, 2026

    32nd International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

    Dubai, UAE
    April 27-28, 2026

    37th International Congress on Prevention of Diabetes and Complications

    Vancouver, Canada
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    May 25-26, 2026

    2nd World congress on Endocrinology and Metabolic syndrome

    Rome, Italy
    June 08-09, 2026

    3rd International Congress on Endocrinology and Complications of Diabetes

    Rome, Italy
    June 15-16, 2026

    35th International Diabetes and Healthcare Conference

    Paris, France
    June 25-26, 2026

    6th European Endocrinology and Diabetes Congress

    London, UK
    June 25-26, 2026

    5th International Summit on Hormonal Disorders

    London, UK
    June 25-26, 2026

    28th World Congress on Diabetes and Endocrine Disorders

    London, UK
    August 17-18, 2026

    6th International Conference on Endocrinology and Diabetes

    Toronto, Canada
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 23-24, 2026

    24th Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France

    Immune Therapies for Type 1 Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in